We’re trying out a new feature here at Barrons Stocks to Watch Today, which will look at the best-performing stock in the S&P 500 each day.
Francesco Libassi/Zuma Press
And no, we didn’t accidentally republish yesterday’s post about Skyworks Solutions (SWKS). Skyworks Solutions is once again today’s hottest stock. The semiconductor manufacturer–and Apple (AAPL) supplier– followed up yesterday’s 4.4% rise with 6.4% gain to $77.02, as it once again rode Apple’s coattails higher. The iPhone maker gained 3.4% to $115.57.
But it wasn’t all Apple today. There was also a positive analyst note from Oppenheimer’sRick Schafer and Joshua Buchalter, who call Skyworks, which has gained just 0.2% this year, “misunderstood” and “mis-priced.” They explain why:
buy penny stocks: Kate Spade & Company(KATE)
- [By Ben Levisohn]
Coach (COH) rose to the top of the S&P 500 today after reports that Kate Spade (KATE) had put itself up for sale caused shares of fashion-accessory retailers to rise.
- [By Lisa Levin]
Kate Spade & Co (NASDAQ: KATE) was down, falling around 14 percent to $19.60 after it was reported the company would spend more time to negotiate the Coach Inc (NYSE: COH) offer.
- [By Ben Levisohn]
Ever since peaking in late April, Kate Spade’s (KATE) shares have been in a downward spiral so pronounced that even an amateur technical analyst like myself could draw its trend line lower. Today, however, its shares are soaring after the Wall Street Journal reported that Kate Spade was actively seeking a buyer.
Mizuho’s Betty Chen and Alex Pham run the math on a possible acquisition price:
When we examined historical transactions in the specialty retail sector, we noticed a wide range of valuations. Select relevant transactions to consider would be ~2x EV/Sales Coach (COH) paid for Stuart Weitzman, Samsonites acquisition of Tumi at 14x EV/EBITDA, 13x EV/EBITDA for Joseph A. Banks by Mens Wearhouse (TLRD) and Kerings acquisition of Volcom for 18x EV/EBITDA. We believe potential valuation could be as high as ~2x EV/ Sales and ~14x EV/EBITDA given Kate Spade’s unique growth profile to expand to ~$4bn in revenue (from $1.4bn in FY16) and improving profitability from 12% EBIT margin TY to at least HTeens-LDD, in our view (Coach is 18.7% and Michael Kors (KORS) is 21.3%). On these two metrics, Kate Spade would be valued at $21-23…
We believe the growth profile coupled with the brands unique appeal to Millennials and broad-based success across categories ranging from handbags to apparel and jewelry could be attractive to many buyers, including Coach, which was rumored to be evaluating the company in recent weeks.
The news has sent shares of Kate Spade soaring: They’re up 24% at $18.03 at 2:11 p.m., a gain that has turned this year’s 18% loss as of last night into a 2% gain during afternoon trading.
The move has also put a dent in Kate Spade’s downtrend (and now you’ll see my amateur technical analysis abilities at work):
That’s one way to break a downtrend.
- [By Ben Levisohn]
Kate Spade (KATE) caught a bounce on Wednesday when the Wall Street Journalreported that it was actively seeking a buyer. Since then, we’ve learned that the fashion accessories retailer looks set to auction itself off to the highest bidder, with the process potentially beginning next month, with bidders potentially including Coach (COH) and Michael Kors (KORS). In a note today, SunTrust Robinson Humphrey analystPamela Quintiliano and team contend that Kate Spade could fetch as much as $23 a share:
Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.
Shares of Kate Spade have gained 1.1% to $18.70 at 2:08 p.m. today, while Coach has declined 0.2% to $34.95, Michael Kors is little changed at $42.86, Oxford Industries has fallen 0.7% to $60.38, Columbia Sportswear has climbed 1.4% to $58.60, and Sequential Brands Group has jumped 3.7% to $4.77.
buy penny stocks: Novo Nordisk A/S(NVO)
- [By Paul Ausick]
Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.
- [By Brian Orelli]
Global Blood Therapeutics (NASDAQ:GBT) is up 20% at 3:42 p.m. EST after Reuters reported that Novo Nordisk (NYSE:NVO) has approached the biotech about a potential acquisition.
- [By James E. Brumley]
When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.
In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.
While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.
As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’
buy penny stocks: Mitcham Industries Inc.(MIND)
- [By Monica Gerson]
Mitcham Industries, Inc. (NASDAQ: MIND) is projected to post a quarterly loss at $0.36 per share on revenue of $10.99 million.
Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.
buy penny stocks: Open Text Corporation(OTEX)
- [By WWW.MONEYSHOW.COM]
One split announcement came from OpenText Inc. (OTEX) — a stock we had already added to our portfolio back in July, 2014; it has since done very well.
buy penny stocks: Student Transportation Inc(STB)
- [By Monica Gerson]
Student Transportation Inc (NASDAQ: STB) is estimated to post its quarterly earnings at $0.04 per share on revenue of $167.40 million.
Exar Corporation (NYSE: EXAR) is projected to post its quarterly earnings at $0.09 per share on revenue of $38.38 million.
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested shorting small cap school bus transportation services stockStudent Transportation (NASDAQ: STB):
buy penny stocks: Liberty Global plc(LBTYA)
- [By Alex Webb]
Kabel Deutschland is a key part of Vodafones expansion strategy as the carrier looks for ways to boost revenue and lock in customers with Internet and television offers in addition to wireless service. Kabel Deutschland is the biggest cable company in Germany, Vodafones largest market, and had drawn a rival bid from John Malones Liberty Global Plc. (LBTYA)